SlideShare a Scribd company logo
Prepared by : Yahya Farwan.
University of Science and Technology Hospital, Sana’a ,Yemen, 2023
.
Objectives
2
1. To know the meaning of proteinuria and albuminuria
2. To identify the types of proteinuria
3. To identify the complications of proteinuria
4. To identify the clinical assessment of proteinuria
5. To identify the lines of treatment of proteinuria
I
Table of Contents
3
1.1 Definitions of Proteinuria ……………………………….. 1
1.2 Classifications of Proteinuria …………………………… 2
1.3 Complications of Proteinuria …………………………… 10
2.1 History Taking ………………………………………….. 12
2.2 Physical Examination .……………………..…………… 21
2.3 Investigations …………………………………….…..…. 25
3.1 Approach Considerations ……………………………….. 32
3.2 Non-Specific Treatment ……………………….……...… 33
3.3 Specific Treatment ………………………………...……. 34
1. Overview
.
2 Clinical Assessment of Proteinuria
4. Summary ……………….....………........................…. 34
.
3 Treatment of Proteinuria
II
.
5 Resources……………….....………....................……... 35
4
List of abbreviations
• AER Mean albumin excretion rate
• CKD Chronic kidney disease
• PCT Proximal convoluted tubules
• LL Lower limb
• MD Diabetes mellitus
• HTN Hypertension
• GN Glomerulonephritis
• Cr Creatinine
• ANA Anti-nuclear antibody
• RBS Random blood sugar
• KUB Kidney-ureter-bladder X-ray
• ASO Anti-streptolysin O
• ACEIs Angiotensin-converting-enzyme inhibitors
• ARBs Angiotensin receptor blockers
• CCBs Calcium channel blockers
• CHF Congestive heart failure
III
• SBP Spontaneous bacterial peritonitis
• PO By mouth
• RAS Renal artery stenosis
• ATN Acute tubular necrosis
• CT Computed tomography
• MRA Magnetic resonance angiography
• ELIS Enzyme-linked immunoabsorbent assay
• MMF Mycophenolate mofetil
5
Definitions of Proteinuria
1.1
1.1 Definitions of Proteinuria
 Normal urinary protein excretion is < 150 mg/24 hours and consists mostly of secreted proteins
such as Tamm-Horsfall proteins.
 Proteinuria is the the urinary excretion of >150 mg /24 hours.
 The normal mean albumin excretion rate (AER) is 5-10 mg/day.
 Nephrotic-range proteinuria is defined as proteinuria greater than 3.5 g / 24 hours.
 Persistent proteinuria proteinuria for more than 3 months.
 Proteinuria can be accompanied by other clinical abnormalities :
Elevated BUN and S.creatinine, ABNL urine sediment.
1
• AER between 30 to 300 mg/day is called microalbuminuria.
• Levels greater than 300 mg/day are called macroalbuminuria.
7
Classifications of Proteinuria
1.2
8
1.2 Classifications of Proteinuria
1. According to quantity:
A. Microalbuminuria
B. Macroalbuminria
2. According to origin:
A. Prerenal
B. Renal:
• Glomerular proteinuria
• Tubular proteinuria
• Mixed
C. Post-renal proteinuria
3. Isolated (benign proteinuria)
A. Orthostatic proteinuria
B. Transient proteinuria
2
A. Microalbuminemia:
• Urine albumin excretion of 30–300 mg/day.
• Early sign of diabetic and hypertensive nephropathy.
B. Macroalbuminemia:
• Urine albumin excretion > 300 mg/day.
• Standard urine dipstick tests can be used for detection.
According to quantity:
1.
3
1.2 Classifications of Proteinuria
• Increased production of low-molecular-weight proteins → Overwhelming the
reabsorption capacity of the PCT → Proteinuria
 Causes:
• Multiple myeloma→ Bence Jones proteins
• Hemolysis → Hemoglobin.
• Rhabdomyolysis → Myoglobin .
A. Pre-renal proteinuria
4
1.2 Classifications of Proteinuria
According to origin:
2.
• Damage to the glomeruli → increased permeability of the glomerular
filtration barrier → urinary protein excretion
• Characteristic finding: appearance of large proteins in the urine, primarily albumin.
• Causes of glomerular proteinuria:
Primary glomerular disease:
1. Minimal change glomerular disease
2. Membranous nephropathy
3. Focal segmental glomerulosclerosis
4. Congenital nephrotic syndrome
Secondary glomerular disease:
1. Nephritic syndromes
2. DM and HTN
3. Systemic lupus erythematosus
4. Cryoglobulinaemic disease
5. Henoch–Schonlein syndrome
6. Drugs :NSAIDs, gold, penicillamine
.
1 Glomerular proteinuria
5
1.2 Classifications of Proteinuria
B. Renal proteinuria
• Damage to the PCT → failure to reabsorb small proteins in the tubules
→ urinary protein excretion, typically beta-2 microglobulin without large proteins.
• The amount of proteinuria is usually < 2 g/day.
• Causes:
▪ Tubulointerstitial nephritis
▪ Nephrolithiasis
▪ Analgesics
▪ Immunosuppressive agents
▪ Acute renal failure.
Found in diseases that affect both the glomeruli and the tubules (e.g., CKD)
.
2 Tubular proteinuria
.
3 Mixed proteinuria
6
1.2 Classifications of Proteinuria
• Physiological proteinuria
Proteins that are being produced in the tubules (Tamm-Horsfall protein)
• Pathological proteinuria
Abnormalities affecting urinary tract from the renal pelvis to the urethra:
▪ Stones
▪ Inflammatory: Ureteritis, Prostatitis, Cystitis, Urethritis.
▪ Neoplastic
▪ Traumatic
C. Post-renal proteinuria
7
1.2 Classifications of Proteinuria
14
1.2 Classifications of Proteinuria
8
▪ Defined as isolated proteinuria < 1 g/day
▪ Very common; mostly affects younger individuals
▪ No treatment necessary; excellent prognosis
Benign proteinuria :
3.
1. Orthostatic proteinuria (postural proteinuria) :
• Increased protein excretion only in the upright position for long time.
• More common in tall, thin adolescents or adults less than 30 years old.
• Dx: The patient has no proteinuria in early morning samples but has low-grade proteinuria
at the end of the day.
2. Transient proteinuria :
• Most common cause of isolated proteinuria in children
• Causes: heavy exertion, Acute illness, Fever, Seizures.
9
1.2 Classifications of Proteinuria
16
Complications of Proteinuria
1.3
1. Pulmonary edema due to fluid overload
2. Acute kidney injury due to intravascular depletion and progressive kidney disease
3. Increased risk of bacterial infection, including SBP
4. Increased risk of arterial and venous thrombosis, including renal vein thrombosis
5. Increased risk of cardiovascular disease
1.3 Complications of Proteinuria
10
18
CLINICAL ASSESSMENT OF
PROTEINURIA
2
Clinical Assessment
• Mild to moderate proteinuria may be asymptomatic.
• The majority of patients with proteinuria are asymptomatic, and proteinuria will be
detected in the course of routine laboratory testing conducted to evaluate
systemic disease.
• Considering the more common and benign causes of proteinuria first is important.
11
20
HISTORY TAKING
2.1
2.1 History Taking
How old are
you and what
is your job ?
I’m 28 years old
and I’m
bodyguard,i came
for regular
screening.
Maybe orthostatic proteinuria
Proteinuria (less than 1g/day)
observed in tall, thin adolescent
or adults younger than 30 years
12
Hello dair,
What’s your
complaint ?
I have fever
rof hguoc dna
2 days
Transtent proteinuria can be
caused by Acute illness, fever,
seizures and physical exertion
13
2.1 History Taking
Do you have
fever, chills,
flank pain,
nausea,
vomiting
Yes Doctor,
Urinary tract infections
14
2.1 History Taking
Did you suffer from
URTI?
Yes Doctor, it
occurred
before one
week.
Post-infectious
glomerulonephritis
15
2.1 History Taking
Do you
complaining of
fever, night
sweats, weight
loss, or bone
pain?
mmm..
Yes, all of
them
Malignancies :
Multiple myeloma
Tumors of the kidney, lung,
colon, stomach or breast
16
2.1 History Taking
Did you have Hx of
hepatitis, tuberculosis,
malaria, syphilis,
HIV,or endocarditis?
Yes Doctor.
TB
17
Infections remote to the kidney
2.1 History Taking
Do you have HTN,
DM,Heart failure,chronic
inflammatory disease or
hypercholesterolemia?
Yes Doctor, I
have T1DM
for 17 years
and HTN for 5
years .
Nephropathy secondary to
systemic diseases .
18
2.1 History Taking
Do you taking any
medication, including
over-the-counter or
herbal remedies ?
Yes Doctor,
NSAIDs
kidney injury due to
medications:
Analgesics
Immunosuppressants
Gold and mercury
Penicillamine
19
2.1 History Taking
Do you have
family history
of kidney
disease or
malignancy?
Yes, Polycystic
kidney disease
Congenital nephrotic syndrome
Malignancy
PKD
20
2.1 History Taking
PHYSICAL EXAMINATION
2.2
2.2 Physical Examination
I will examine the
JVP
Pulse rate
Blood pressure
Heart sounds
Assess intravascular volume status
Ammm
😪
21
I’ll look for Edema
and then i will listen to your
Breath sounds (which may be
decreased due to pleural
effusions)
Assess extravascular volume status
Okay
22
2.2 Physical Examination
I well examine you for retinopathy
,rash, joint swelling or deformity
,stigmata of CLD
,lymphadenopathy, cardiac
murmurs.
Examine the patient for signs of systemic disease
Okay
23
2.2 Physical Examination
Lastly, I well examine you for
Venous thrombosis and
Peritonitis
Examine the patient for complications
Okay
24
2.2 Physical Examination
INVESTIGATIONS
2.3
Specific Laboratory
Imaging
2.3 Investigations
25
Standard urine dipstick test:
• Primarily detects albumin > 300 mg/day.
• Protein detected by urine dipstick should always be quantified with either a 24-hour urine
collection or protein-creatinine or albumin-creatinine ratio on random urine samples.
• Results interpretation:
• Trace = 50 to 150 mg/day; 1+ = 150 to 500 mg/day; 2+ = 0.5 to 1.5 g/day;
3+ = 2 to 5 g/day; 4+ = >5 g/day
2.3 Investigations
○ Initial test once proteinuria is detected by dipstick test → examination of urine sediment:
• RBC casts → GN
• WBC casts → pyelonephritis or interstitial nephritis
• Fatty casts → nephrotic syndrome (lipiduria)
• Granular stsac → acute tubular necrosis
○ If urine casts are positive → treat the cause and repeat urinalysis for proteinuria
○ If urinalysis confirms the presence of protein, a 24-hour urine collection (for albumin and Cr)
is appropriate to quantify the proteinuria.
26
2.3 Investigations
Urinalysis :
24-hour urine albumin:
Normal range <30mg/day
Microalbuminuria 30-300mg/ 24 hours
Macroalbuminuria >300mg/24 hours
Nephrotic syndrome ≥ 3.5 g/24hours
27
2.3 Investigations
24-hour urine collection (for albumin and Cr)
Spot urine protein or albumin/creatinine ratio :
Normal <50mg/g or <0.2mg/mg
Proteinuria ≥ 150mg/g or ≥0.2 mg/mg
▪ Corresponds to albumin excretion of 30 to 300 mg/day.
▪ This is below the range of sensitivity of standard dipsticks.
▪ Special tests can detect microgrm amount of albumin, including:
.
1 Radioimmunoassay the most sensitive and specific test for microalbuminuria.
.
2 Specific urine dipstick tests
3. Sulfosalicylic acid test
.
4 ELISA
28
2.3 Investigations
Test for microalbuminuria
■ BUN and Cr— for renal function
■ Serum albuminaimenimublaopyh detaicossa rof
■ ABG and electrolytes for associated metabolic acidosis
■ CBC—to detect anemia due to renal failure
■ Urine and plasma electrophoresis— to rule out tubulointerstitial diseases and multiple myeloma
■ Lipid profile —for associated dyslipidemia
■ Autoantibodies - If indicated, including ASO titers, ANA, anti-DNA, complement levels (C3 and C4).
■ Hepatitis B, hepatitis C, and HIV serologies - If indicated
29
2.3 Investigations
Other tests
○ Renal ultrasound:
• Hydronephrosis suggests obstructive nephropathy.
• Small, smooth kidneys suggests chronic parenchymal renal disease.
• Renal asymmetry suggests RAS
• Renal enlargement can occur in ATN, renal vein thrombosis, and renal infiltration.
○ Plain abdominal film (KUB) if renal stones or nephrocalcinosis suspected.
○ Contrast CT angiography or Gadolinium- enhanced MRA for Atherosclerotic RAS
○ CXR –Infiltrates, CHF, pleural effusion .
○ Renal biopsy
30
Imaging Studies
2.3 Investigations
Kidney Biopsy Treat
underlying
disease, if
unknown ;
kidney
biopsy
31
Treatment of Proteinuria
3
3.1 approach considerations
● Nonspecific treatment –
Treatment that is applicable irrespective of
the underlying cause, assuming the patient has no contraindications to the therapy
● Specific treatment –
Treatment that depends on the underlying renal or
nonrenal cause and, in particular, whether or not the injury is immune mediated
● Referral to a nephrologist is indicated for any patient who develops proteinuria,
especially those with any adverse prognostic markers (eg, rise in albumin
excretion of > 1 g/day), or any worsening in kidney function.
32
▪ Restriction of dietary salts and proteins .
▪ Cessation of smoking
▪ Vitamin D and calcium supplements.
▪ Pneumococcal vaccine
▪ Treatment of infection
3.2 Non-Specific Treatment
33
▪ Drugs:
▪ Diuretics :loop diuretic or a combination of diuretics such as a thiazide and loop diuretics .
▪ ACE inhibitors and ARBs
▪ CCB: if ACEIs or ARBs are contraindicated.
▪ Anticoagulants
▪ Treatment of dyslipidemiasnitats htiw
● Minimal change disease : most respond to prednisone (adequate dose and duration),
but may relapse ,cyclophosphamide or cyclosporine may be used for frequent relapses
● Focal segmental glomerulosclerosis : high dose long-term steroids will lead to remission in about
1/3 of patients +_ MMF ,calcineurin inhibitors
● Membranoproliferative GN :steroid +-azathioprine, MMF
● Diabetic Nephropathy : strict control of blood sugar _+ARBS,ACE-I
● SLE Nephropathy:
Therapy : depend on class ,for all class use HCQ + prednisolone
for class 3, 4 , add cyclophosphamide or MMF (mycophenolate mofetil).
3.3 Specific Treatment
34
SUMMARY
4
Summary
35
• Normal urinary protein excretion is < 150 mg/24 hours
• Proteinuria is the the urinary excretion of >150 mg /24 hours.
• Nephrotic-range proteinuria is defined as greater than 3.5 g / 24 hour
• Glomerular proteinuria mainly albumin while tubular proteinuria LMW proteins
• Prerenal and postrenal proteinuria occurs due to systemic diseases and urinary tract
abnormalities, respectively.
• Orthostatic and transient proteinuria are benign and have excellent prognosis
• Cardiovascular and pulmonary abnormalities, infections, VTE and AKI are main
complications of proteinuria
• The majority of patients with proteinuria are asymptomatic
• Considering the more common and benign causes of proteinuria first is important.
• Renal US is the most useful imaging study of kidney abnormalities
• Nonspecific treatment can be applied in all types of proteinuria
• ACEIs and ARBs can be used in patients with proteinuria regardless of the cause
• CCB can be used if there is contraindication of ACEIs or ARBs.
• Specific treatment of proteinuria according to the underlying cause.
Resources
4
Resources
☆ https://emedicine.medscape.com/article/238158-clinical?src=mbl_msp_android&ref=share
☆ https://www.amboss.com/us/knowledge/Proteinuria
☆ STEP-UP to MEDICINE, FOURTH EDITION
☆ HARRISON’S MANUAL OF MEDICINE, 19th Edition.
☆ Current medical diagnosis and treatment 2022
.
☆ Nephrology Lectures Book of Dr. Elham Al-tholaimi,UST,Sanaa,Yemen , 2021
.
☆
36
“
52
Thanks

More Related Content

What's hot

Monogenic hypertension prof. ayman hammad
Monogenic hypertension prof. ayman hammad Monogenic hypertension prof. ayman hammad
Monogenic hypertension prof. ayman hammad
FarragBahbah
 
Renal Function Tests by Dr.Ankur Puri
Renal Function Tests by Dr.Ankur PuriRenal Function Tests by Dr.Ankur Puri
Renal Function Tests by Dr.Ankur PuriAnkur Puri
 
approach to proteinuria.pptx
approach to proteinuria.pptxapproach to proteinuria.pptx
approach to proteinuria.pptx
YahyaFarwan
 
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal NassarUpdates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
MNDU net
 
1-Kidney Function Test .pptx
1-Kidney Function Test .pptx1-Kidney Function Test .pptx
1-Kidney Function Test .pptx
Ashishkumar1790963
 
Is It Diabetic Nephropathy? (When to Biopsy?) - Dr. Gawad
Is It Diabetic Nephropathy? (When to Biopsy?) - Dr. GawadIs It Diabetic Nephropathy? (When to Biopsy?) - Dr. Gawad
Is It Diabetic Nephropathy? (When to Biopsy?) - Dr. Gawad
NephroTube - Dr.Gawad
 
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
NephroTube - Dr.Gawad
 
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. GawadIgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
NephroTube - Dr.Gawad
 
Cardiorenal syndrome
Cardiorenal syndromeCardiorenal syndrome
Cardiorenal syndrome
Praveen Nagula
 
Rapidly progressive glomerulonephritis
Rapidly progressive glomerulonephritisRapidly progressive glomerulonephritis
Rapidly progressive glomerulonephritis
ajith joseph
 
Gastrocon 2016 - Hepatorenal Syndrome
Gastrocon 2016 - Hepatorenal SyndromeGastrocon 2016 - Hepatorenal Syndrome
Gastrocon 2016 - Hepatorenal Syndrome
ApolloGleaneagls
 
ANCA vasculitis
ANCA vasculitisANCA vasculitis
ANCA vasculitis
Diana Girnita
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
Prateek Singh
 
Chronic Kidney Disease-Mineral Bone Disease
Chronic Kidney Disease-Mineral Bone DiseaseChronic Kidney Disease-Mineral Bone Disease
Chronic Kidney Disease-Mineral Bone Disease
Waleed El-Refaey
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Estimation of glomerular filtration rate
Estimation of glomerular filtration rateEstimation of glomerular filtration rate
Estimation of glomerular filtration rate
Arun Raj
 
ADA
ADAADA
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
Manjunath Anvekar
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
Manoj Prabhakar
 

What's hot (20)

Monogenic hypertension prof. ayman hammad
Monogenic hypertension prof. ayman hammad Monogenic hypertension prof. ayman hammad
Monogenic hypertension prof. ayman hammad
 
Renal Function Tests by Dr.Ankur Puri
Renal Function Tests by Dr.Ankur PuriRenal Function Tests by Dr.Ankur Puri
Renal Function Tests by Dr.Ankur Puri
 
approach to proteinuria.pptx
approach to proteinuria.pptxapproach to proteinuria.pptx
approach to proteinuria.pptx
 
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal NassarUpdates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
 
1-Kidney Function Test .pptx
1-Kidney Function Test .pptx1-Kidney Function Test .pptx
1-Kidney Function Test .pptx
 
Is It Diabetic Nephropathy? (When to Biopsy?) - Dr. Gawad
Is It Diabetic Nephropathy? (When to Biopsy?) - Dr. GawadIs It Diabetic Nephropathy? (When to Biopsy?) - Dr. Gawad
Is It Diabetic Nephropathy? (When to Biopsy?) - Dr. Gawad
 
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
 
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. GawadIgA NEPHROPATHY (CLOSING THE LOOP)  - Dr. Gawad
IgA NEPHROPATHY (CLOSING THE LOOP) - Dr. Gawad
 
Hypertension and renal diseases
Hypertension and renal diseasesHypertension and renal diseases
Hypertension and renal diseases
 
Cardiorenal syndrome
Cardiorenal syndromeCardiorenal syndrome
Cardiorenal syndrome
 
Rapidly progressive glomerulonephritis
Rapidly progressive glomerulonephritisRapidly progressive glomerulonephritis
Rapidly progressive glomerulonephritis
 
Gastrocon 2016 - Hepatorenal Syndrome
Gastrocon 2016 - Hepatorenal SyndromeGastrocon 2016 - Hepatorenal Syndrome
Gastrocon 2016 - Hepatorenal Syndrome
 
ANCA vasculitis
ANCA vasculitisANCA vasculitis
ANCA vasculitis
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
 
Chronic Kidney Disease-Mineral Bone Disease
Chronic Kidney Disease-Mineral Bone DiseaseChronic Kidney Disease-Mineral Bone Disease
Chronic Kidney Disease-Mineral Bone Disease
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Estimation of glomerular filtration rate
Estimation of glomerular filtration rateEstimation of glomerular filtration rate
Estimation of glomerular filtration rate
 
ADA
ADAADA
ADA
 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 

Similar to Approach of proteinuria, Y.Farwan.pptx

Proteinuria Evaluation
Proteinuria EvaluationProteinuria Evaluation
Proteinuria Evaluation
tarun kumar
 
Proteinuriadr.mohmed yasssen
Proteinuriadr.mohmed yasssenProteinuriadr.mohmed yasssen
Proteinuriadr.mohmed yasssen
FAARRAG
 
A Case Presentation on Chronic Kidney Disease
A Case Presentation on Chronic Kidney DiseaseA Case Presentation on Chronic Kidney Disease
A Case Presentation on Chronic Kidney Disease
DR. METI.BHARATH KUMAR
 
Nephrotic syndrome sharanpur 2022 .ppt
Nephrotic syndrome sharanpur 2022 .pptNephrotic syndrome sharanpur 2022 .ppt
Nephrotic syndrome sharanpur 2022 .ppt
sandeepkumarGarg4
 
Chronic Kidney Disease Management and care
Chronic Kidney Disease Management and careChronic Kidney Disease Management and care
Chronic Kidney Disease Management and care
sachintutor
 
LECTURE NEPHROTIC SYNDROME.pdf
LECTURE NEPHROTIC SYNDROME.pdfLECTURE NEPHROTIC SYNDROME.pdf
LECTURE NEPHROTIC SYNDROME.pdf
ssuser222ad9
 
nephrotic syndrome final TREATMENT EVALUATION.ppt
nephrotic syndrome final TREATMENT EVALUATION.pptnephrotic syndrome final TREATMENT EVALUATION.ppt
nephrotic syndrome final TREATMENT EVALUATION.ppt
BIMALESHYADAV2
 
Evaluation of proteinuria in children ppt
Evaluation of proteinuria in children pptEvaluation of proteinuria in children ppt
Evaluation of proteinuria in children ppt
Shane Watson
 
Clinical case discussions
Clinical case discussions Clinical case discussions
Clinical case discussions
Namrata Chhabra
 
Unraveling the Enigma of Proteinuria A Deep Dive into Its Connection with Kid...
Unraveling the Enigma of Proteinuria A Deep Dive into Its Connection with Kid...Unraveling the Enigma of Proteinuria A Deep Dive into Its Connection with Kid...
Unraveling the Enigma of Proteinuria A Deep Dive into Its Connection with Kid...
jsomal
 
Chronic Kidney Disease, CKD, Nephrology,
Chronic Kidney Disease, CKD, Nephrology, Chronic Kidney Disease, CKD, Nephrology,
Chronic Kidney Disease, CKD, Nephrology,
Dee Evardone
 
Proteinuria
ProteinuriaProteinuria
Proteinuria
Khalid Ramadan
 
Chronic Renal Failure (End Stage Renal Failure)
Chronic Renal Failure (End Stage Renal Failure)Chronic Renal Failure (End Stage Renal Failure)
Chronic Renal Failure (End Stage Renal Failure)
Sachin Dwivedi
 
Nephrotic.pptx
Nephrotic.pptxNephrotic.pptx
Nephrotic.pptx
NikkyFauzany
 
Acute renal failure, chronic renal failure - Pathology - ATOT
Acute renal failure, chronic renal failure - Pathology - ATOTAcute renal failure, chronic renal failure - Pathology - ATOT
Acute renal failure, chronic renal failure - Pathology - ATOT
Dr. Salman Ansari
 
Urinary system disorders.pptx
Urinary system disorders.pptxUrinary system disorders.pptx
Urinary system disorders.pptx
MohammedAbdela7
 
Estimation of proteinuria and Approach..
Estimation of proteinuria and Approach..Estimation of proteinuria and Approach..
Estimation of proteinuria and Approach..
drsajidlashari1
 
5-part 1-acute and chronic renal failure.ppt
5-part 1-acute and chronic renal failure.ppt5-part 1-acute and chronic renal failure.ppt
5-part 1-acute and chronic renal failure.ppt
AbdallahAlasal1
 
Nephrorounds3 2015final-150907110921-lva1-app6892
Nephrorounds3 2015final-150907110921-lva1-app6892Nephrorounds3 2015final-150907110921-lva1-app6892
Nephrorounds3 2015final-150907110921-lva1-app6892
Gordhan Das asani
 
Renal disorder 2
Renal disorder 2Renal disorder 2
Renal disorder 2
Jamilah AlQahtani
 

Similar to Approach of proteinuria, Y.Farwan.pptx (20)

Proteinuria Evaluation
Proteinuria EvaluationProteinuria Evaluation
Proteinuria Evaluation
 
Proteinuriadr.mohmed yasssen
Proteinuriadr.mohmed yasssenProteinuriadr.mohmed yasssen
Proteinuriadr.mohmed yasssen
 
A Case Presentation on Chronic Kidney Disease
A Case Presentation on Chronic Kidney DiseaseA Case Presentation on Chronic Kidney Disease
A Case Presentation on Chronic Kidney Disease
 
Nephrotic syndrome sharanpur 2022 .ppt
Nephrotic syndrome sharanpur 2022 .pptNephrotic syndrome sharanpur 2022 .ppt
Nephrotic syndrome sharanpur 2022 .ppt
 
Chronic Kidney Disease Management and care
Chronic Kidney Disease Management and careChronic Kidney Disease Management and care
Chronic Kidney Disease Management and care
 
LECTURE NEPHROTIC SYNDROME.pdf
LECTURE NEPHROTIC SYNDROME.pdfLECTURE NEPHROTIC SYNDROME.pdf
LECTURE NEPHROTIC SYNDROME.pdf
 
nephrotic syndrome final TREATMENT EVALUATION.ppt
nephrotic syndrome final TREATMENT EVALUATION.pptnephrotic syndrome final TREATMENT EVALUATION.ppt
nephrotic syndrome final TREATMENT EVALUATION.ppt
 
Evaluation of proteinuria in children ppt
Evaluation of proteinuria in children pptEvaluation of proteinuria in children ppt
Evaluation of proteinuria in children ppt
 
Clinical case discussions
Clinical case discussions Clinical case discussions
Clinical case discussions
 
Unraveling the Enigma of Proteinuria A Deep Dive into Its Connection with Kid...
Unraveling the Enigma of Proteinuria A Deep Dive into Its Connection with Kid...Unraveling the Enigma of Proteinuria A Deep Dive into Its Connection with Kid...
Unraveling the Enigma of Proteinuria A Deep Dive into Its Connection with Kid...
 
Chronic Kidney Disease, CKD, Nephrology,
Chronic Kidney Disease, CKD, Nephrology, Chronic Kidney Disease, CKD, Nephrology,
Chronic Kidney Disease, CKD, Nephrology,
 
Proteinuria
ProteinuriaProteinuria
Proteinuria
 
Chronic Renal Failure (End Stage Renal Failure)
Chronic Renal Failure (End Stage Renal Failure)Chronic Renal Failure (End Stage Renal Failure)
Chronic Renal Failure (End Stage Renal Failure)
 
Nephrotic.pptx
Nephrotic.pptxNephrotic.pptx
Nephrotic.pptx
 
Acute renal failure, chronic renal failure - Pathology - ATOT
Acute renal failure, chronic renal failure - Pathology - ATOTAcute renal failure, chronic renal failure - Pathology - ATOT
Acute renal failure, chronic renal failure - Pathology - ATOT
 
Urinary system disorders.pptx
Urinary system disorders.pptxUrinary system disorders.pptx
Urinary system disorders.pptx
 
Estimation of proteinuria and Approach..
Estimation of proteinuria and Approach..Estimation of proteinuria and Approach..
Estimation of proteinuria and Approach..
 
5-part 1-acute and chronic renal failure.ppt
5-part 1-acute and chronic renal failure.ppt5-part 1-acute and chronic renal failure.ppt
5-part 1-acute and chronic renal failure.ppt
 
Nephrorounds3 2015final-150907110921-lva1-app6892
Nephrorounds3 2015final-150907110921-lva1-app6892Nephrorounds3 2015final-150907110921-lva1-app6892
Nephrorounds3 2015final-150907110921-lva1-app6892
 
Renal disorder 2
Renal disorder 2Renal disorder 2
Renal disorder 2
 

Recently uploaded

Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 

Recently uploaded (20)

Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 

Approach of proteinuria, Y.Farwan.pptx

  • 1. Prepared by : Yahya Farwan. University of Science and Technology Hospital, Sana’a ,Yemen, 2023 .
  • 2. Objectives 2 1. To know the meaning of proteinuria and albuminuria 2. To identify the types of proteinuria 3. To identify the complications of proteinuria 4. To identify the clinical assessment of proteinuria 5. To identify the lines of treatment of proteinuria I
  • 3. Table of Contents 3 1.1 Definitions of Proteinuria ……………………………….. 1 1.2 Classifications of Proteinuria …………………………… 2 1.3 Complications of Proteinuria …………………………… 10 2.1 History Taking ………………………………………….. 12 2.2 Physical Examination .……………………..…………… 21 2.3 Investigations …………………………………….…..…. 25 3.1 Approach Considerations ……………………………….. 32 3.2 Non-Specific Treatment ……………………….……...… 33 3.3 Specific Treatment ………………………………...……. 34 1. Overview . 2 Clinical Assessment of Proteinuria 4. Summary ……………….....………........................…. 34 . 3 Treatment of Proteinuria II . 5 Resources……………….....………....................……... 35
  • 4. 4 List of abbreviations • AER Mean albumin excretion rate • CKD Chronic kidney disease • PCT Proximal convoluted tubules • LL Lower limb • MD Diabetes mellitus • HTN Hypertension • GN Glomerulonephritis • Cr Creatinine • ANA Anti-nuclear antibody • RBS Random blood sugar • KUB Kidney-ureter-bladder X-ray • ASO Anti-streptolysin O • ACEIs Angiotensin-converting-enzyme inhibitors • ARBs Angiotensin receptor blockers • CCBs Calcium channel blockers • CHF Congestive heart failure III • SBP Spontaneous bacterial peritonitis • PO By mouth • RAS Renal artery stenosis • ATN Acute tubular necrosis • CT Computed tomography • MRA Magnetic resonance angiography • ELIS Enzyme-linked immunoabsorbent assay • MMF Mycophenolate mofetil
  • 6. 1.1 Definitions of Proteinuria  Normal urinary protein excretion is < 150 mg/24 hours and consists mostly of secreted proteins such as Tamm-Horsfall proteins.  Proteinuria is the the urinary excretion of >150 mg /24 hours.  The normal mean albumin excretion rate (AER) is 5-10 mg/day.  Nephrotic-range proteinuria is defined as proteinuria greater than 3.5 g / 24 hours.  Persistent proteinuria proteinuria for more than 3 months.  Proteinuria can be accompanied by other clinical abnormalities : Elevated BUN and S.creatinine, ABNL urine sediment. 1 • AER between 30 to 300 mg/day is called microalbuminuria. • Levels greater than 300 mg/day are called macroalbuminuria.
  • 8. 8 1.2 Classifications of Proteinuria 1. According to quantity: A. Microalbuminuria B. Macroalbuminria 2. According to origin: A. Prerenal B. Renal: • Glomerular proteinuria • Tubular proteinuria • Mixed C. Post-renal proteinuria 3. Isolated (benign proteinuria) A. Orthostatic proteinuria B. Transient proteinuria 2
  • 9. A. Microalbuminemia: • Urine albumin excretion of 30–300 mg/day. • Early sign of diabetic and hypertensive nephropathy. B. Macroalbuminemia: • Urine albumin excretion > 300 mg/day. • Standard urine dipstick tests can be used for detection. According to quantity: 1. 3 1.2 Classifications of Proteinuria
  • 10. • Increased production of low-molecular-weight proteins → Overwhelming the reabsorption capacity of the PCT → Proteinuria  Causes: • Multiple myeloma→ Bence Jones proteins • Hemolysis → Hemoglobin. • Rhabdomyolysis → Myoglobin . A. Pre-renal proteinuria 4 1.2 Classifications of Proteinuria According to origin: 2.
  • 11. • Damage to the glomeruli → increased permeability of the glomerular filtration barrier → urinary protein excretion • Characteristic finding: appearance of large proteins in the urine, primarily albumin. • Causes of glomerular proteinuria: Primary glomerular disease: 1. Minimal change glomerular disease 2. Membranous nephropathy 3. Focal segmental glomerulosclerosis 4. Congenital nephrotic syndrome Secondary glomerular disease: 1. Nephritic syndromes 2. DM and HTN 3. Systemic lupus erythematosus 4. Cryoglobulinaemic disease 5. Henoch–Schonlein syndrome 6. Drugs :NSAIDs, gold, penicillamine . 1 Glomerular proteinuria 5 1.2 Classifications of Proteinuria B. Renal proteinuria
  • 12. • Damage to the PCT → failure to reabsorb small proteins in the tubules → urinary protein excretion, typically beta-2 microglobulin without large proteins. • The amount of proteinuria is usually < 2 g/day. • Causes: ▪ Tubulointerstitial nephritis ▪ Nephrolithiasis ▪ Analgesics ▪ Immunosuppressive agents ▪ Acute renal failure. Found in diseases that affect both the glomeruli and the tubules (e.g., CKD) . 2 Tubular proteinuria . 3 Mixed proteinuria 6 1.2 Classifications of Proteinuria
  • 13. • Physiological proteinuria Proteins that are being produced in the tubules (Tamm-Horsfall protein) • Pathological proteinuria Abnormalities affecting urinary tract from the renal pelvis to the urethra: ▪ Stones ▪ Inflammatory: Ureteritis, Prostatitis, Cystitis, Urethritis. ▪ Neoplastic ▪ Traumatic C. Post-renal proteinuria 7 1.2 Classifications of Proteinuria
  • 14. 14 1.2 Classifications of Proteinuria 8
  • 15. ▪ Defined as isolated proteinuria < 1 g/day ▪ Very common; mostly affects younger individuals ▪ No treatment necessary; excellent prognosis Benign proteinuria : 3. 1. Orthostatic proteinuria (postural proteinuria) : • Increased protein excretion only in the upright position for long time. • More common in tall, thin adolescents or adults less than 30 years old. • Dx: The patient has no proteinuria in early morning samples but has low-grade proteinuria at the end of the day. 2. Transient proteinuria : • Most common cause of isolated proteinuria in children • Causes: heavy exertion, Acute illness, Fever, Seizures. 9 1.2 Classifications of Proteinuria
  • 17. 1. Pulmonary edema due to fluid overload 2. Acute kidney injury due to intravascular depletion and progressive kidney disease 3. Increased risk of bacterial infection, including SBP 4. Increased risk of arterial and venous thrombosis, including renal vein thrombosis 5. Increased risk of cardiovascular disease 1.3 Complications of Proteinuria 10
  • 19. Clinical Assessment • Mild to moderate proteinuria may be asymptomatic. • The majority of patients with proteinuria are asymptomatic, and proteinuria will be detected in the course of routine laboratory testing conducted to evaluate systemic disease. • Considering the more common and benign causes of proteinuria first is important. 11
  • 21. 2.1 History Taking How old are you and what is your job ? I’m 28 years old and I’m bodyguard,i came for regular screening. Maybe orthostatic proteinuria Proteinuria (less than 1g/day) observed in tall, thin adolescent or adults younger than 30 years 12
  • 22. Hello dair, What’s your complaint ? I have fever rof hguoc dna 2 days Transtent proteinuria can be caused by Acute illness, fever, seizures and physical exertion 13 2.1 History Taking
  • 23. Do you have fever, chills, flank pain, nausea, vomiting Yes Doctor, Urinary tract infections 14 2.1 History Taking
  • 24. Did you suffer from URTI? Yes Doctor, it occurred before one week. Post-infectious glomerulonephritis 15 2.1 History Taking
  • 25. Do you complaining of fever, night sweats, weight loss, or bone pain? mmm.. Yes, all of them Malignancies : Multiple myeloma Tumors of the kidney, lung, colon, stomach or breast 16 2.1 History Taking
  • 26. Did you have Hx of hepatitis, tuberculosis, malaria, syphilis, HIV,or endocarditis? Yes Doctor. TB 17 Infections remote to the kidney 2.1 History Taking
  • 27. Do you have HTN, DM,Heart failure,chronic inflammatory disease or hypercholesterolemia? Yes Doctor, I have T1DM for 17 years and HTN for 5 years . Nephropathy secondary to systemic diseases . 18 2.1 History Taking
  • 28. Do you taking any medication, including over-the-counter or herbal remedies ? Yes Doctor, NSAIDs kidney injury due to medications: Analgesics Immunosuppressants Gold and mercury Penicillamine 19 2.1 History Taking
  • 29. Do you have family history of kidney disease or malignancy? Yes, Polycystic kidney disease Congenital nephrotic syndrome Malignancy PKD 20 2.1 History Taking
  • 31. 2.2 Physical Examination I will examine the JVP Pulse rate Blood pressure Heart sounds Assess intravascular volume status Ammm 😪 21
  • 32. I’ll look for Edema and then i will listen to your Breath sounds (which may be decreased due to pleural effusions) Assess extravascular volume status Okay 22 2.2 Physical Examination
  • 33. I well examine you for retinopathy ,rash, joint swelling or deformity ,stigmata of CLD ,lymphadenopathy, cardiac murmurs. Examine the patient for signs of systemic disease Okay 23 2.2 Physical Examination
  • 34. Lastly, I well examine you for Venous thrombosis and Peritonitis Examine the patient for complications Okay 24 2.2 Physical Examination
  • 37. 25 Standard urine dipstick test: • Primarily detects albumin > 300 mg/day. • Protein detected by urine dipstick should always be quantified with either a 24-hour urine collection or protein-creatinine or albumin-creatinine ratio on random urine samples. • Results interpretation: • Trace = 50 to 150 mg/day; 1+ = 150 to 500 mg/day; 2+ = 0.5 to 1.5 g/day; 3+ = 2 to 5 g/day; 4+ = >5 g/day 2.3 Investigations
  • 38. ○ Initial test once proteinuria is detected by dipstick test → examination of urine sediment: • RBC casts → GN • WBC casts → pyelonephritis or interstitial nephritis • Fatty casts → nephrotic syndrome (lipiduria) • Granular stsac → acute tubular necrosis ○ If urine casts are positive → treat the cause and repeat urinalysis for proteinuria ○ If urinalysis confirms the presence of protein, a 24-hour urine collection (for albumin and Cr) is appropriate to quantify the proteinuria. 26 2.3 Investigations Urinalysis :
  • 39. 24-hour urine albumin: Normal range <30mg/day Microalbuminuria 30-300mg/ 24 hours Macroalbuminuria >300mg/24 hours Nephrotic syndrome ≥ 3.5 g/24hours 27 2.3 Investigations 24-hour urine collection (for albumin and Cr) Spot urine protein or albumin/creatinine ratio : Normal <50mg/g or <0.2mg/mg Proteinuria ≥ 150mg/g or ≥0.2 mg/mg
  • 40. ▪ Corresponds to albumin excretion of 30 to 300 mg/day. ▪ This is below the range of sensitivity of standard dipsticks. ▪ Special tests can detect microgrm amount of albumin, including: . 1 Radioimmunoassay the most sensitive and specific test for microalbuminuria. . 2 Specific urine dipstick tests 3. Sulfosalicylic acid test . 4 ELISA 28 2.3 Investigations Test for microalbuminuria
  • 41. ■ BUN and Cr— for renal function ■ Serum albuminaimenimublaopyh detaicossa rof ■ ABG and electrolytes for associated metabolic acidosis ■ CBC—to detect anemia due to renal failure ■ Urine and plasma electrophoresis— to rule out tubulointerstitial diseases and multiple myeloma ■ Lipid profile —for associated dyslipidemia ■ Autoantibodies - If indicated, including ASO titers, ANA, anti-DNA, complement levels (C3 and C4). ■ Hepatitis B, hepatitis C, and HIV serologies - If indicated 29 2.3 Investigations Other tests
  • 42. ○ Renal ultrasound: • Hydronephrosis suggests obstructive nephropathy. • Small, smooth kidneys suggests chronic parenchymal renal disease. • Renal asymmetry suggests RAS • Renal enlargement can occur in ATN, renal vein thrombosis, and renal infiltration. ○ Plain abdominal film (KUB) if renal stones or nephrocalcinosis suspected. ○ Contrast CT angiography or Gadolinium- enhanced MRA for Atherosclerotic RAS ○ CXR –Infiltrates, CHF, pleural effusion . ○ Renal biopsy 30 Imaging Studies 2.3 Investigations
  • 43. Kidney Biopsy Treat underlying disease, if unknown ; kidney biopsy 31
  • 45. 3.1 approach considerations ● Nonspecific treatment – Treatment that is applicable irrespective of the underlying cause, assuming the patient has no contraindications to the therapy ● Specific treatment – Treatment that depends on the underlying renal or nonrenal cause and, in particular, whether or not the injury is immune mediated ● Referral to a nephrologist is indicated for any patient who develops proteinuria, especially those with any adverse prognostic markers (eg, rise in albumin excretion of > 1 g/day), or any worsening in kidney function. 32
  • 46. ▪ Restriction of dietary salts and proteins . ▪ Cessation of smoking ▪ Vitamin D and calcium supplements. ▪ Pneumococcal vaccine ▪ Treatment of infection 3.2 Non-Specific Treatment 33 ▪ Drugs: ▪ Diuretics :loop diuretic or a combination of diuretics such as a thiazide and loop diuretics . ▪ ACE inhibitors and ARBs ▪ CCB: if ACEIs or ARBs are contraindicated. ▪ Anticoagulants ▪ Treatment of dyslipidemiasnitats htiw
  • 47. ● Minimal change disease : most respond to prednisone (adequate dose and duration), but may relapse ,cyclophosphamide or cyclosporine may be used for frequent relapses ● Focal segmental glomerulosclerosis : high dose long-term steroids will lead to remission in about 1/3 of patients +_ MMF ,calcineurin inhibitors ● Membranoproliferative GN :steroid +-azathioprine, MMF ● Diabetic Nephropathy : strict control of blood sugar _+ARBS,ACE-I ● SLE Nephropathy: Therapy : depend on class ,for all class use HCQ + prednisolone for class 3, 4 , add cyclophosphamide or MMF (mycophenolate mofetil). 3.3 Specific Treatment 34
  • 49. Summary 35 • Normal urinary protein excretion is < 150 mg/24 hours • Proteinuria is the the urinary excretion of >150 mg /24 hours. • Nephrotic-range proteinuria is defined as greater than 3.5 g / 24 hour • Glomerular proteinuria mainly albumin while tubular proteinuria LMW proteins • Prerenal and postrenal proteinuria occurs due to systemic diseases and urinary tract abnormalities, respectively. • Orthostatic and transient proteinuria are benign and have excellent prognosis • Cardiovascular and pulmonary abnormalities, infections, VTE and AKI are main complications of proteinuria • The majority of patients with proteinuria are asymptomatic • Considering the more common and benign causes of proteinuria first is important. • Renal US is the most useful imaging study of kidney abnormalities • Nonspecific treatment can be applied in all types of proteinuria • ACEIs and ARBs can be used in patients with proteinuria regardless of the cause • CCB can be used if there is contraindication of ACEIs or ARBs. • Specific treatment of proteinuria according to the underlying cause.
  • 51. Resources ☆ https://emedicine.medscape.com/article/238158-clinical?src=mbl_msp_android&ref=share ☆ https://www.amboss.com/us/knowledge/Proteinuria ☆ STEP-UP to MEDICINE, FOURTH EDITION ☆ HARRISON’S MANUAL OF MEDICINE, 19th Edition. ☆ Current medical diagnosis and treatment 2022 . ☆ Nephrology Lectures Book of Dr. Elham Al-tholaimi,UST,Sanaa,Yemen , 2021 . ☆ 36